BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6388965)

  • 1. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorbance nephelometry of C1q-precipitable immune complexes: method comparisons and clinical correlations.
    Levinson SS; Goldman J
    Clin Chem; 1983 Dec; 29(12):2082-6. PubMed ID: 6605819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera.
    Krapf F; Renger D; Schedel I; Leiendecker K; Leyssens H; Deicher H
    J Immunol Methods; 1982 Oct; 54(1):107-17. PubMed ID: 7142715
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration and differentiation of circulating immune complexes in chronic inflammatory rheumatic diseases using a semiautomated PEG-precipitation laser nephelometer test].
    Geissler N; Kemper A; Krapf E; Renger D; Schedel I; Deicher H
    Z Rheumatol; 1985; 44(2):57-63. PubMed ID: 4050141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.
    Krauledat PB; Krapf FE; Manger B; Kalden JR
    Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of using various methods in the determination of serum immune complex levels].
    Mijusković Z; Radojicić C; Lilić D; Todorović P; Dujić A
    Vojnosanit Pregl; 1989; 46(4):256-60. PubMed ID: 2800418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of circulating immune complexes in the pathogenesis of diabetes mellitus.
    Kilpatrick JM; Virella G
    Acta Diabetol Lat; 1982; 19(2):107-39. PubMed ID: 7051711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating immune complexes in man; precipitation of immune complexes with polyethylene glycol and their characterization by Clq bound to immunoglobulins].
    Grangeot L; Pillot J
    C R Acad Hebd Seances Acad Sci D; 1975 Mar; 280(9):1201-3. PubMed ID: 811395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of circulating immune complexes by three techniques using polyethylene glycol (author's transl)].
    Digeon M; Bach JF
    Nouv Presse Med; 1977 Dec; 6(43):4031-7. PubMed ID: 600749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complex-like activity associated with abnormal serum lipoproteins in systemic erythematosus.
    Smith GW; Hannan SF; Scott PJ; Simpson IJ
    Clin Exp Immunol; 1982 Apr; 48(1):8-16. PubMed ID: 6979451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.